Holding(s) in Company

RNS Number:2992V
Biocare Solutions PLC
20 April 2007



TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES


1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):

Biocare Solutions plc


2. Reason for the notification (please state Yes/No): ( )


An acquisition or disposal of voting rights: ( no )


An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: ( no )


An event changing the breakdown of voting rights: ( no )


Other (please specify) : ( yes ) Clarification of holding pursuant to
transitional provisions of DTR


3. Full name of person(s) subject to the notification obligation (iii):

SAAD Investments Company Limited


4. Full name of shareholder(s) (if different from 3.) (iv):


5. Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):

n/a.................


6. Date on which issuer notified:

20 April 2007


7. Threshold(s) that is/are crossed or reached:

n/a.................


8. Notified details:

n/a.................



A: Voting rights attached to shares

Class/type of shares if possible        Situation previous to the
using the ISIN CODE                    Triggering transaction (vi)
                                   Number of    Number of voting
                                   shares       Rights (viii)
                                                          
Ordinary shares of 1p each;         3,662,864       3,662,864




Resulting situation after the triggering transaction (vii)

Class/type of shares Number of shares  Number of voting rights    % of voting rights
if possible using                      (ix)
the ISIN CODE

                     Direct            Direct (x) Indirect (xi)   Direct    Indirect




B: Financial Instruments

Resulting situation after the triggering transaction (xii)

Type of     Expiration Date  Exercise/Conversion Number of voting     % of voting
financial   (xiii)           Period/ Date (xiv)  rights that may be   rights
instrument                                       acquired if the
                                                 instrument is
                                                 exercised/
                                                 converted.







Total (A+B)
Number of voting       % of voting
rights                 rights

  3,662,864             3.996%



9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):

n/a.................


Proxy Voting:


10. Name of the proxy holder:

n/a.................


11. Number of voting rights proxy holder will cease to hold:

n/a.................


12. Date on which proxy holder will cease to hold voting rights:

n/a.................

13. Additional information:

n/a.................


14. Contact name:

n/a.................


15. Contact telephone number:

n/a.................


Annex to Notification Of Major Interests In Shares (xvi) N/A


A: Identity of the person or legal entity subject to the notification obligation


Full name (including legal form for legal entities):

.................


Contact address (registered office for legal entities):

.................


Phone number:

.................


Other useful information (at least legal representative for legal persons):

.................


B: Identity of the notifier, if applicable (xvii)


Full name:

.................


Contact address:

.................


Phone number:

.................


Other useful information (e.g. functional relationship with the person or legal
entity subject to the notification obligation):

.................


C: Additional information :

.................







                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
HOLPUUGACUPMGMU
Biocare (LSE:BSN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024